Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06235112 · ClinicalTrials.gov registry record · NA
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
A NA study of Coronary Artery Disease, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 1
- Study location
NCT06235112 is a NA study of Coronary Artery Disease that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 1,500 participants, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06235112, a NA study of Coronary Artery Disease, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.
Conditions Studied
Interventions
- DEVICE Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2024-07-31 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06235112
The ClinicalTrials.gov registry entry for NCT06235112 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,280-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (17% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment is the first listed.
NCT06235112 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06235112 about?
NCT06235112 is a clinical study titled "AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention". AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intell...
What is the current status of trial NCT06235112?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2024-07-31. Estimated completion is 2027-12-01.
What conditions does trial NCT06235112 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT06235112?
The interventions under investigation include: Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment (DEVICE).
Who is sponsoring clinical trial NCT06235112?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06235112 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.